Patel, Jyoti http://orcid.org/0000-0002-7550-2094
Meng, Jie http://orcid.org/0000-0002-6439-7292
Le, Hoa http://orcid.org/0000-0003-4395-1685
Tanaka, Yoko http://orcid.org/0000-0002-9180-8763
Phani, Sudarshan
Salas, Maribel http://orcid.org/0000-0001-5634-1558
Wu, Chuntao
Sternberg, David
Esker, Stephen
Anderson, Jeffrey P. http://orcid.org/0000-0003-4048-3919
Crowley, Aaron http://orcid.org/0000-0002-1203-9223
Zhou, Summera Q.
Lieb, Camryn http://orcid.org/0009-0009-4336-5572
Sun, Haiyan http://orcid.org/0009-0001-2348-5130
Doan, Quan V.
Santhanagopal, Anu
Reckamp, Karen L.
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 27 March 2024
Accepted: 20 June 2024
First Online: 3 July 2024
Declarations
:
: Jyoti Patel is an employee of Northwestern University and reports an advisory role for AstraZeneca, AbbVie, Bristol Myers Squibb, Takeda, Genentech, and Daiichi Sankyo. Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Chuntao Wu, David Sternberg, and Stephen Esker are employees of Daiichi Sankyo and hold stock in Daiichi Sankyo. Maribel Salas is an employee of Bayer Inc. and was an employee of Daiichi Sankyo at the time of the study. Anu Santhanagopal is an employee of Boehringer Ingelheim and was an employee of Daiichi Sankyo at the time of the study. Summera Q. Zhou is an employee of Daiichi Sankyo and was an employee of Genesis Research Group at the time of the study. Jeffrey P. Anderson, Aaron Crowley, Camryn Lieb, and Haiyan Sun are employees of Genesis Research Group, whose company received research funding from Daiichi Sankyo to complete this study. Quan V. Doan was an employee of Genesis Research Group at the time of the study and has no additional affiliations to declare. Karen L. Reckamp is an employee of Cedars-Sinai Medical Center and reports receiving research funding to her institution from Mirati, Genentech, Blueprint, Calithera, Daiichi Sankyo, Elevation Oncology, and Janssen and reports receiving honoraria as a consultant for Amgen, AstraZeneca, Blueprint, Daiichi Sankyo, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck KGaA, Mirati, Seagen, and Takeda.
: This study was exempt from review by an institutional review board because the database was compliant with the Health Insurance Portability and Accountability Act, the data did not include any identifiable patient information, and the study did not involve human subjects, as defined by 45 CFR 46.102(f)(2). Permission was granted from the database owner (Flatiron Health) to access the database.